Skip to main content
. 2017 Apr 4;8(20):33614–33620. doi: 10.18632/oncotarget.16833

Table 1. Baseline characteristics.

Age at Diagnosis, Median (95% CI) 54 (25–72)
Gender, Female 11 (57.9%)
ECOG PS
 0—1 16 (84.2%)
 >2 3 (15.8%)
Nephrectomy Performed 15 (78.9%)
Clear cell histology 13 (68.4%)
IMDC Risk Category
 Favorable 4 (21.1%)
 Intermediate 11 (57.9%)
 Poor 4 (21.1%)
LDH U/L, Median (95% CI) 188 (96.0–4913.0)
Metastatic Disease
 Lung 11 (57.9%)
 Bones 8 (42.1%)
 Lymph Nodes 5 (26.3%)
 CNS 1 (5.3%)
 Other 4 (21.1%)